Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levofloxacin for Acute Ischemic Stroke
NCT05799326Recruiting
- Start
- Jun 2023
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in ischemic stroke comparing Levofloxacin with Placebo (2 arms). Primary endpoint: National Institutes of Health Stroke Scale. Started Jun 2023; status: recruiting.
02
Drugs
levofloxacin
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT05799326.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05799326.